Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sawai Group Holdings CoSWGHF 51 Return-on-Tangible-Equity is 7.23% as of Jun. 2026, which is 2% above its 10-year median of 7.06. GuruFocus rates SWGHF with a GF Score™ of 51/100 and a GF Value™ of $16.91. The stock has 4 warning signs investors should review. Among 902 Drug Manufacturers companies, Sawai Group Holdings Co ranks worse than 55.76% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Sawai Group Holdings Co's annualized net income for the quarter that ended in Jun. 2026 was $75 Mil. Sawai Group Holdings Co's average shareholder tangible equity for the quarter that ended in Jun. 2026 was $1,147 Mil. Therefore, Sawai Group Holdings Co's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2026 was 6.55%.
The historical rank and industry rank for Sawai Group Holdings Co's Return-on-Tangible-Equity or its related term are showing as below:
SWGHF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -17.26 Med: 7.06 Max: 7.49
Current: 5.38
During the past 13 years, Sawai Group Holdings Co's highest Return-on-Tangible-Equity was 7.49%. The lowest was -17.26%. And the median was 7.06%.
SWGHF's Return-on-Tangible-Equity is ranked worse than 55.76% of 902
companies
in the Drug Manufacturers industry
Industry Median: 7.515
vs SWGHF: 5.38
Sawai Group Holdings Co (OTCPK:SWGHF) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Sawai Group Holdings Co Return-on-Tangible-Equity Related Terms
Sawai Group Holdings Co Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Sawai Group Holdings Co's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sawai Group Holdings Co Return-on-Tangible-Equity Chart
SWGHF vs ZTS: Return-on-Tangible-Equity Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Sawai Group Holdings Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sawai Group Holdings Co Return-on-Tangible-Equity vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sawai Group Holdings Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Sawai Group Holdings Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Jun. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 7.23% mean?
Sawai Group Holdings Co (SWGHF) has a Return-on-Tangible-Equity of 7.23% as of Jun. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Sawai Group Holdings Co and its competitors. This is near median its historical median of 7.06. According to the industry distribution chart, Sawai Group Holdings Co ranks #503 out of 902 companies in the Drug Manufacturers industry, placing it in the top 55.8%.
Is Sawai Group Holdings Co's Return-on-Tangible-Equity too high?
Sawai Group Holdings Co's current Return-on-Tangible-Equity of 7.23% is near median its 10-year median of 7.06. The Drug Manufacturers industry median Return-on-Tangible-Equity is 7.52. Sawai Group Holdings Co's value of 7.23% is 3.8% below this industry median. Based on the distribution chart, Sawai Group Holdings Co ranks #503 out of 902 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Sawai Group Holdings Co has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does Sawai Group Holdings Co's Return-on-Tangible-Equity compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sawai Group Holdings Co ranks #503 out of 902 companies for Return-on-Tangible-Equity. This places Sawai Group Holdings Co in the lower half of its industry. The industry median Return-on-Tangible-Equity is 7.52. Sawai Group Holdings Co's value of 7.23% is 3.8% below this benchmark. While the company's 10-year median is 7.06 vs. the industry median of 7.52, Sawai Group Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Drug Manufacturers company?
The median Return-on-Tangible-Equity among Drug Manufacturers companies is 7.52, based on 902 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sawai Group Holdings Co's current Return-on-Tangible-Equity of 7.23% is 3.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Sawai Group Holdings Co and its competitors. For the Drug Manufacturers industry, the median Return-on-Tangible-Equity is 7.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sawai Group Holdings Co's current Return-on-Tangible-Equity is 7.23%, which is near median its own 10-year median of 7.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sawai Group Holdings Co stock overvalued right now?
Sawai Group Holdings Co (SWGHF) has a current Return-on-Tangible-Equity of 7.23%. The stock's GF Value™ is $16.91, compared to a current price of $11.52 — trading 31.9% below its estimated fair value. The current Return-on-Tangible-Equity is 7.23%, which is near median its 10-year median of 7.06 and 3.8% below the Drug Manufacturers industry median of 7.52. Sawai Group Holdings Co's overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Sawai Group Holdings Co (SWGHF), the current Return-on-Tangible-Equity is 7.23% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sawai Group Holdings Co (SWGHF) Overvalued in 2026?
Based on GuruFocus' analysis, Sawai Group Holdings Co stock appears to be undervalued.
The current stock price of $11.52 is trading 31.9% below its estimated GF Value™ of $16.91.
Key valuation signals for SWGHF:
Return-on-Tangible-Equity: 7.23% (near median its 10-year median of 7.06)
GF Value™: $16.91 vs. price of $11.52 (31.9% below fair value)
Industry Position: 3.8% below the Drug Manufacturers median (#503 of 902)
No single metric tells the full story. See the SWGHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sawai Group Holdings Co Ltd is engaged in providing management support or guidance to domestic and foreign companies engaged in businesses related to medical and healthcare services, such as the manufacture and sale of pharmaceutical products and medical equipment, as well as various businesses incidental or related to the same.
51GF Score
Get the complete analysis for SWGHF
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SWGHF has been successfully added to your 
